| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 40.004 | 0 | 0 | 0 | 0 | 0 | 300 | 1.003 | 1.046 | 1.297 |
| Total Income - EUR | 43.354 | 0 | 0 | 187 | 0 | 0 | 300 | 1.003 | 1.046 | 1.297 |
| Total Expenses - EUR | 40.037 | 33.926 | 14.931 | 97.501 | 2.356 | 2.107 | 1.803 | 2.358 | 1.419 | 1.915 |
| Gross Profit/Loss - EUR | 3.317 | -33.926 | -14.931 | -97.314 | -2.356 | -2.107 | -1.503 | -1.355 | -373 | -618 |
| Net Profit/Loss - EUR | 2.773 | -33.926 | -14.931 | -101.982 | -2.356 | -2.107 | -1.512 | -1.385 | -373 | -618 |
| Employees | 4 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Devest Farmatech Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 24.811 | 22.216 | 20.654 | 19.111 | 17.600 | 16.146 | 14.693 | 13.641 | 12.504 | 11.346 |
| Current Assets | 235.512 | 231.202 | 229.286 | 55.080 | 53.705 | 53.119 | 51.998 | 52.535 | 53.263 | 54.061 |
| Inventories | 74.119 | 73.389 | 72.285 | 28.080 | 27.537 | 27.015 | 26.415 | 26.497 | 26.417 | 26.269 |
| Receivables | 159.883 | 157.869 | 156.333 | 26.429 | 25.983 | 25.786 | 25.203 | 25.225 | 25.012 | 25.250 |
| Cash | 1.510 | -56 | 667 | 571 | 186 | 319 | 380 | 813 | 1.834 | 2.542 |
| Shareholders Funds | -15.121 | -48.892 | -62.996 | -163.821 | -163.005 | -162.022 | -159.941 | -161.823 | -161.705 | -161.419 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 275.444 | 302.310 | 312.936 | 238.013 | 234.309 | 231.288 | 226.633 | 227.999 | 227.472 | 226.826 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4675 - 4675" | |||||||||
| CAEN Financial Year |
4675
|
|||||||||
Comments - Devest Farmatech Srl